{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:14Z","timestamp":1791576134595,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejps.2019.105104","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T02:03:07Z","timestamp":1571968987000},"page":"105104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis"],"prefix":"10.1016","volume":"142","author":[{"given":"A.G.","family":"McCloskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Miskelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6766-6320","authenticated-orcid":false,"given":"A.M.","family":"McKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.105104_bib0001","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.2003.tb03176.x","article-title":"The gut hormone peptide YY regulates appetite","volume":"994","author":"Batterham","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2019.105104_bib0002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jnutbio.2015.02.001","article-title":"Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids","volume":"26","author":"Bhaswant","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejps.2019.105104_bib0003","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0026-0495(98)90304-3","article-title":"Differential effects of fat and sucrose on body composition in A\/J and C57BL\/6 mice","volume":"47","author":"Black","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.ejps.2019.105104_bib0004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jmedgenet-2015-103065","article-title":"Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels","volume":"52","author":"Bonnefond","year":"2015","journal-title":"J. Med. Genet."},{"issue":"13","key":"10.1016\/j.ejps.2019.105104_bib0005","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan g protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.ejps.2019.105104_bib0006","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/oby.2007.608","article-title":"High-fat diets: modeling the metabolic disorders of human obesity in rodents","volume":"15","author":"Buettner","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ejps.2019.105104_bib0007","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bcp.2013.12.016","article-title":"Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr(3)(4)(7), Ser(3)(5)(0), and Ser(3)(5)(7) in the C-terminal tail","volume":"87","author":"Burns","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejps.2019.105104_bib0008","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1017\/S000711451500118X","article-title":"Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1\/FFA4 agonist with potential effect against metabolic diseases","volume":"113","author":"Christiansen","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejps.2019.105104_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/0253-7613.68425","article-title":"Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals","volume":"42","author":"Davis","year":"2010","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105104_bib0010","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/bjp.2008.43","article-title":"Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pacreatic beta-cell line, BRIN-BD11","volume":"153","author":"Dhayal","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105104_bib0011","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd2245","article-title":"Sitagliptin","volume":"6","author":"Drucker","year":"2007","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.ejps.2019.105104_bib0012","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejps.2019.105104_bib0013","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1463-1326.2010.01265.x","article-title":"Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic \u03b2-cells","volume":"12","author":"Gehrmann","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejps.2019.105104_bib0014","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2019.105104_bib0015","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1210\/en.2006-1403","article-title":"Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells","volume":"148","author":"Iakoubov","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejps.2019.105104_bib0016","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prostaglandins.2009.05.003","article-title":"Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis","volume":"89","author":"Ichimura","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ejps.2019.105104_bib0017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature10798","article-title":"Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human","volume":"483","author":"Ichimura","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2019.105104_bib0018","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2019.105104_bib0019","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/dom.13004","article-title":"Fasiglifam for glycaemic control in people with type 2 diabetes: a phase III, placebo-controlled study","volume":"19","author":"Marcinak","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejps.2019.105104_bib0020","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1194\/jlr.M025874","article-title":"Lipid-mediated release of GLP-1 by mouse taste buds from circumvallate papillae: putative involvement of GPR120 and impact on taste sensitivity","volume":"53","author":"Martin","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2019.105104_bib0021","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2337\/diab.45.8.1132","article-title":"Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion","volume":"45","author":"McClenaghan","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ejps.2019.105104_bib0022","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.12356","article-title":"Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice","volume":"170","author":"McKillop","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105104_bib0023","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1007\/s00125-016-4108-z","article-title":"Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice","volume":"59","author":"McKillop","year":"2016","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ejps.2019.105104_bib0024","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/acs.chemrev.6b00056","article-title":"and hudson, B. complex pharmacology of free fatty acid receptors","volume":"117","author":"Milligan","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2019.105104_bib0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1515\/hsz-2013-0255","article-title":"Activation of GPR119 by fatty acid agonists augments insulin release from clonal beta-cells and isolated pancreatic islets and improves glucose tolerance in mice","volume":"395","author":"Moran","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejps.2019.105104_bib0026","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/dom.12330","article-title":"Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic beta-cells","volume":"16","author":"Moran","year":"2014","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejps.2019.105104_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00592-015-0826-9","article-title":"G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis","volume":"53","author":"Moran","year":"2016","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejps.2019.105104_bib0028","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2019.105104_bib0029","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm.3614","article-title":"A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice","volume":"20","author":"Oh","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2019.105104_bib0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/toxsci\/kfx040","article-title":"Fasiglifam (TAK-875): mechanistic investigation and retrospective identification of hazards for drug induced liver injury","volume":"163","author":"Otieno","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejps.2019.105104_bib0031","doi-asserted-by":"crossref","first-page":"e88227","DOI":"10.1371\/journal.pone.0088227","article-title":"Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion","volume":"9","author":"Paulsen","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2019.105104_bib0032","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/dom.12921","article-title":"Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: a randomized, 12-week trial","volume":"19","author":"Peng","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejps.2019.105104_bib0033","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/en.2017-00090","article-title":"Long-Chain free fatty acid receptor GPR120 mediates oil-induced GIP secretion through CCK in male mice","volume":"158","author":"Sankoda","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejps.2019.105104_bib0034","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.bmcl.2014.05.012","article-title":"Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4\/GPR120)","volume":"24","author":"Sparks","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ejps.2019.105104_bib0035","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00125-014-3213-0","article-title":"GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of langerhans","volume":"57","author":"Stone","year":"2014","journal-title":"Diabetologia"},{"issue":"22","key":"10.1016\/j.ejps.2019.105104_bib0036","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1074\/jbc.M114.568683","article-title":"Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice","volume":"289","author":"Suckow","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2019.105104_bib0037","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2013.11.010","article-title":"Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion","volume":"94","author":"Tanaka","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2019.105104_bib0038","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00210-007-0250-y","article-title":"Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells","volume":"377","author":"Tanaka","year":"2008","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2019.105104_bib0039","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-nutr-071714-034410","article-title":"Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4\/GPR120","volume":"35","author":"Ulven","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.ejps.2019.105104_bib0040","first-page":"658","article-title":"Dietary obesity in the mouse: interaction of strain with diet composition","volume":"268","author":"West","year":"1995","journal-title":"Am. J. Physiol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871930377X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871930377X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:50:53Z","timestamp":1760529053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809871930377X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"alternative-id":["S092809871930377X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105104","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105104"}}